Skip to main content
. 2019 May;16(2):234–246. doi: 10.20892/j.issn.2095-3941.2018.0284

S3.

IC50 (μM) for each drug at 0 and 4 Gy in a panel of colorectal cancer cell lines

Cell line 5-FU IC50 Vorinostat IC50 PI-103 IC50 Olaparib IC50 Rucaparib IC50 Mitoxantrone IC50
IC50 was calculated using Graphpad Prism following normalisation for radiation effect, and is shown in μM, with 95% confidence limits in parenthesis.
* Where the curve shape did not allow calculation of IC50 in Graphpad, IC50 was calculated manually by interpolation.
* > indicates the highest concentration tested in cell lines where the IC 50 was not reached.
LS411 0 Gy 24.67
(17.58 to 35.46)
6.79
(3.99 to 11.91)
5.23
(3.47 to 8.12)
24.46
(15.71 to 38.89)
*62.18 16.75
(12.32 to 22.98)
LS411 4 Gy 21.95
(12.37 to 40.8)
14.55
(9.69 to 22.27)
2.76
(1.57 to 4.96)
2.11
(1.09 to 4.18)
1.72
(0.49 to 8.54)
7.8
(5.63 to 10.89)
VACO5 0 Gy 2.54
(1.95 to 3.35)
3.45
(2.47 to 4.9)
1.91
(1.05 to 3.58)
10.5
(3.83 to 29.59)
34.03
(21.2 to 58.03)
3.49
(0.87 to 14.64)
VACO5 4 Gy 0.99
(0.83 to 1.19)
3.37
(2.85 to 4)
0.48
(0.34 to 0.71)
0.75
(0.43 to 1.3)
3.07
(0.61 to 11.91)
1.24
(0.56 to 2.99)
RKO 0 Gy 2.51
(1.93 to 3.29)
6.51
(3.89 to 11.26)
1.55
(0.95 to 2.54)
8.63
(4.32 to 17.22)
61.23
(30.07 to 167.4)
9.75
(6.21 to 15.44)
RKO 4 Gy 1.15
(0.73 to 1.90)
2.14
(1.2 to 4.15)
0.33
(0.20 to 0.57)
0.35
(0.15 to 0.78)
0.3
(0.03 to 1.59)
2.9
(1.59 to 5.46)
HT29 0 Gy 9.12
(6.67 to 12.66)
3.47
(2.42 to 5.03)
* >20 17.93
(4.14 to 75.29)
51.82
(33.61 to 86.34)
6.58
(1.24 to 78.99)
HT29 4 Gy 6.6
(5.24 to 8.36)
4.18
(2.6 to 6.94)
* 12.94 2.21
(1.25 to 3.55)
5.48
(2.49 to 11.75)
3.06
(0.88 to 12)
OXCO4 0 Gy 16.71
(14.13 to 19.85)
6.09
(3.69 to 10.41)
2.42
(1.82 to 3.24)
26.88
(16.82 to 43.79)
13.11
(10.42 to 16.58)
0.89
(0.61 to 1.33)
OXCO4 4 Gy 9.45
(7.92 to 11.32)
3.82
(2.69 to 5.49)
1.13
(0.87 to 1.47)
6.07
(4.73 to 7.82)
2.5
(1.74 to 3.61)
0.59
(0.44 to 0.78)
CW2 0 Gy 20.19
(15.17 to 27.24)
4.49
(2.9 to 7.08)
4.97
(3.14 to 8.17)
17.05
(6.48 to 44.79)
36.91
(30.48 to 45.16)
19.81
(11.2 to 35.76)
CW2 4 Gy *20.1 5.33
(3.59 to 7.99)
4.21
(1.49 to 14.87)
* >20 * >30 21.02
(12.56 to 186)
DLD1 0 Gy 8.6
(6.77 to 10.99)
6.26
(3.07 to 13.72)
1.69
(0.94 to 3.08)
* >100 *30.41 4.08
(1.49 to 12.46)
DLD1 4 Gy 7.78
(5.26 to 11.81)
3.25
(2.02 to 5.42)
0.52
(0.29 to 0.95)
1.74
(0.89 to 3.5)
0.44
(0.15 to 2.1)
1.9
(1.33 to 2.72)
CCK81 0 Gy 29.85
(23.48 to 38)
10.4
(5.37 to 21.34)
1.27
(0.92 to 1.76)
>100 *48.51 *16.51
CCK81 4Gy 20.77
(16.64 to 26.01)
7.84
(4.13 to 15.86)
1.07
(0.81 to 1.44)
13.05
(7.62 to 22.53)
45.05
(11.83 to 105.1)
22.6
(11.62 to 60.7)
C10 0 Gy 43.38
(31.27 to 60.93)
2.05
(0.82 to 6.16)
0.98
(0.45 to 2.19)
* >100 23.7
(20.64 to 222.2)
3.92
(1.84 to 8.96)
C10 4 Gy 39.86
(17.15 to 101.3)
10.21
(1.3 to 74.5)
0.53
(0.27 to 1.17)
* >100 22.4
(6.87 to 130)
2.18
(1.14 to 4.29)
SW403 0 Gy 1.31
(0.86 to 2.02)
17.71
(7.57 to 49.28)
* >20 6.18
(1.46 to 26.89)
40.51
(27.91 to 61.56)
2.17
(0.94 to 5.27)
SW403 4 Gy 0.73
(0.49 to 1.09)
7.28
(4.53 to 12.05)
10.81
(5.35 to 27.22)
0.85
(0.28 to 2.46)
12.39
(5.71 to 26.75)
1.46
(0.66 to 3.41)
COLO678 0 Gy 85
(37.7 to 197.4)
8.68
(1.84 to 64.49)
2.3
(1.08 to 5.15)
* >200 * 48.67 5.96
(2.98 to 12.18)
COLO678 4 Gy 81.5
(70.58 to 129.3)
*5.5 2.24
(1.09 to 4.85)
* >200 * 45.79 20.31
(12.29 to 34.44)
SW1222 0 Gy 10.58
(5.80 to 20.42)
41.93
(16.03 to 134)
* >20 16.72
(9.97 to 28.91)
9.78
(4.56 to 22.31)
2.76
(1.63 to 4.8)
SW1222 4 Gy 3.23
(2.19 to 4.75)
4.07
(2.98 to 5.63)
0.75
(0.63 to 0.90)
0.42
(0.32 to 0.56)
* 0.32 0.73
(0.32 to 1.83)
HCA7 0 Gy 27.64
(22.63 to 33.87)
1.29
(0.93 to 1.80)
2.95
(1.71 to 5.26)
3.99
(3.16 to 5.05)
48.51
(35.36 to 68.98)
1.93
(0.57 to 6.89)
HCA7 4 Gy 19.82
(16.49 to 23.89)
0.82
(0.70 to 0.97)
1.14
(0.79 to 1.66)
0.24
(0.18 to 0.32)
0.36
(0.19 to 0.66)
0.75
(0.24 to 2.53)
HT55 0 Gy 10.53
(7.91 to 14.17)
2.11
(1.51 to 3)
2.87
(0.95 to 9.99)
41.07(4.96 to 28.01) 12.2
(8.31 to 18.19)
1.26
(0.86 to 1.85)
HT55 4 Gy 12.03
(8.91 to 16.48)
3.14(1.99 to 5.10) 2.58
(1.85 to 3.63)
7.88
(0.88 to 3.66)
1.47
(0.4 to 5.18)
1.27
(0.79 to 2.08)
C99 0 Gy 3.34
(2.11 to 5.72)
3.53
(1.8 to 7.46)
23.77
(8.94 to 31.98)
14.01
(4.11 to 53.54)
39.28
(21.29 to 81.87)
1.15
(0.58 to 2.31)
C99 4 Gy 4.44
(2.37 to 8.86)
3
(1.66 to 5.92)
0.97
(0.30 to 3.48)
0.44
(0.22 to 0.87)
14.2
(0.16 to 18)
0.49
(0.27 to 0.92)
Cell line AZD-7762 IC50 PF4777 IC50 AZD-6244 IC50 Trametinib IC50 Vemurafenib IC50
LS411 0 Gy 2.69
(1.5 to 6.50)
3.84
(2.91 to 5.08)
11.92
(5.13 to 39.4)
2.03
(0.08 to 25.26)
58.81
(30.19 to 144.8)
LS411 4 Gy 0.41
(0.25 to 0.69)
1.49
(1.06 to 1.83)
6.94
(2.62 to 24.83)
1.81
(0.006 to 48.6)
20.39
(4.63 to 210.7)
RKO 0 Gy 0.02
(0.015 to 0.03)
0.47
(0.31 to 0.71)
*148.75 0.09
(0.03 to 0.3)
15.14
(4.37 to 57.2)
RKO 4 Gy 0.005
(0.004 to 0.008)
0.19
(0.15 to 0.25)
4.62
(0.74 to 46.47)
0.03
(0.01 to 0.07)
4.57
(0.99 to 29.93)
VACO5 0 Gy 0.05
(0.03 to 0.11)
1.5
(1.06 to 2.16)
14.81
(7.95 to 29.18)
0.01
(0.007 to 0.017)
9.37
(6.57 to 13.45)
VACO5 4 Gy 0.01
(0.004 to 0.02)
0.28
(0.23 to 0.34)
7.08
(4.28 to 11.86)
0.003
(0.003 to 0.004)
3.86
(2.6 to 5.84)
HT29 0 Gy 0.03
(0.02 to 0.06)
4.08
(2.58 to 6.89)
2.34(1.02 to 5.62) 0.02
(0.01 to 0.04)
13.1
(5.49 to 32.24)
HT29 4 Gy 0.01
(0.003 to 0.03)
1.57
(1.03 to 2.45)
1.87(0.62 to 6.39) 0.01
(0.007 to 0.02)
11.76
(6.68 to 20.96)
OXCO4 0 Gy 2.14
(1.39 to 3.73)
1.54
(1.08 to 2.22)
3.04
(1.76 to 5.35)
*0.15 14.57
(10.14 to 21.19)
OXCO4 4 Gy 0.17
(0.13 to 0.22)
0.76
(0.54 to 1.09)
0.82
(0.33 to 2.4)
*0.06 10.6
(4.09 to 28.44)
CW2 0 Gy 2.16
(1.17 to 5.32)
26.75
(21.9 to 32.78)
1.72
(0.47 to 9.39)
0.46
(0.2 to 1.24)
*53.05
CW2 4 Gy * >2 20.75
(6.06 to 71.96)
* >10 0.18
(0.076 to 0.44)
*49.07
DLD1 0 Gy 0.14
(0.1 to 0.21)
* 15.02 * >20 * >1 *66.41
DLD1 4 Gy 0.02
(0.01 to 0.05)
5.46
(2.36 to 12.91)
* >20 0.08
(0.02 to 0.59)
33.24
(14.01 to 84.84)
CCK81 0 Gy 0.75
(0.43 to 1.42)
* >10 * >20 *>1 * >160
CCK81 4Gy 0.11
(0.08 to 0.17)
* >10 * >20 * >1 * >160
C10 0 Gy 0.12
(0.1 to 0.15)
*10.08 *25.69 0.68
(0.26 to 3.31)
53.16
(30.73 to 99.45)
C10 4 Gy 0.12
(0.08 to 0.2)
* >10 * >20 0.29
(0.13 to 0.74)
48.79
(23.05 to 119.8)
SW403 0 Gy 0.26
(0.18 to 0.37)
0.79
(0.44 to 1.41)
6.45
(3.02 to 15.7)
*2.03 * >80
SW403 4 Gy 0.13
(0.1 to 0.16)
0.37
(0.22 to 0.62)
1.71
(1.08 to 2.76)
* 1.68 * >80
COLO678 0 Gy * >2 *25.14 1.12
(0.72 to 1.78)
0.006
(0.005 to 0.008)
* >80
COLO678 4 Gy * >2 *25.39 1.47
(1.07 to 2.04)
0.005
(0.002 to 0.01)
* >80
SW1222 0 Gy 0.07
(0.05 to 0.1)
6.26
(4.02 to 10.64)
3.75
(0.64 to 45.5)
0.23
(0.09 to 0.69)
* >160
SW1222 4 Gy 0.02
(0.02 to 0.02)
1.19
(0.76 to 1.91)
0.61
(0.43 to 0.87)
0.04
(0.02 to 0.07)
39.5
(27.01-57.36)
HCA7 0 Gy 0.06
(0.01 to 0.47)
2.37
(1.76 to 3.26)
* >20 0.41
(0.21 to 0.89)
196.8
(178.93 to 231)
HCA7 4 Gy 0.01
(0.00 to 0.14)
0.42
(0.36 to 0.49)
*18.77 0.15
(0.09 to 0.24)
116.7
(64.29 to 256.3)
HT55 0 Gy 0.06
(0.05 to 0.09)
0.97
(0.73 to 1.28)
1.55
(0.28 to 5.02)
0.08
(0.03 to 0.29)
49.39
(15.7 to 169.4)
HT55 4 Gy 0.02
(0.01 to 0.02)
0.37
(0.3 to 0.47)
1.55
(0.41 to 3.33)
0.05
(0.03 to 0.09)
50.77
(22.77 to 132)
C99 0 Gy 0.12
(0.07 to 0.22)
3.75
(1.92 to 8.38)
1.27
(0.32 to 5.5)
0.01
(0.007 to 0.023)
* >160
C99 4 Gy 0.34
(0.07 to 2.32)
1.43
(0.32 to 7.72)
0.38
(0.16 to 1.08)
0.004
(0.002 to 0.007)
* >160